These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35360443)

  • 1. The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis.
    Pan Y; Guo R; Lv Y; Cui D; Xie J
    Can J Gastroenterol Hepatol; 2022; 2022():9035971. PubMed ID: 35360443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
    Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
    Starlinger P; Ahn JC; Mullan A; Gyoeri GP; Pereyra D; Alva-Ruiz R; Hackl H; Reiberger T; Trauner M; Santol J; Simbrunner B; Mandorfer M; Berlakovich G; Kamath PS; Heimbach J
    Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von-Willebrand factor as a predictor of three-month mortality in patients with liver cirrhosis compared to MELD score.
    Curakova Ristovska E; Genadieva-Dimitrova M; Caloska-Ivanova V; Misevski J
    Acta Gastroenterol Belg; 2019; 82(4):487-493. PubMed ID: 31950803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia.
    Kalambokis GN; Oikonomou A; Christou L; Kolaitis NI; Tsianos EV; Christodoulou D; Baltayiannis G
    J Hepatol; 2016 Nov; 65(5):921-928. PubMed ID: 27297911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review: role of elevated plasma von-Willebrand factor as predictor of mortality in patients with chronic liver disease.
    Eidelberg A; Kirubakaran R; Nair SC; Eapen CE; Elias E; Goel A
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1184-1191. PubMed ID: 31498279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand factor and alkaline phosphatase predict re-transplantation-free survival after the first liver transplantation.
    Wannhoff A; Rauber C; Friedrich K; Rupp C; Stremmel W; Weiss KH; Schemmer P; Gotthardt DN
    United European Gastroenterol J; 2017 Feb; 5(1):86-93. PubMed ID: 28405326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis.
    Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V
    J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical value of von Willebrand factor and VITRO score in evaluating disease progression in patients with HBV infection].
    Guan YL; Zhang DZ; Yang YX; Wan RJ; Tang LQ; Zeng WQ; Kang J
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):309-315. PubMed ID: 35462488
    [No Abstract]   [Full Text] [Related]  

  • 12. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.
    Wu H; Yan S; Wang G; Cui S; Zhang C; Zhu Q
    Scand J Gastroenterol; 2015; 50(9):1160-9. PubMed ID: 25877661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.
    Langholm LL; Manon-Jensen T; Karsdal MA; Bendtsen F; Leeming DJ; Møller S
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1040-1048. PubMed ID: 30768435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.
    Maieron A; Salzl P; Peck-Radosavljevic M; Trauner M; Hametner S; Schöfl R; Ferenci P; Ferlitsch M
    Aliment Pharmacol Ther; 2014 Feb; 39(3):331-8. PubMed ID: 24308724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure.
    Prasanna KS; Goel A; Amirtharaj GJ; Ramachandran A; Balasubramanian KA; Mackie I; Zachariah U; Sajith KG; Elias E; Eapen CE
    Indian J Gastroenterol; 2016 Nov; 35(6):432-440. PubMed ID: 27822882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapy.
    Rutter K; Etschmaier A; Ferlitsch M; Maieron A; Hametner S; Horvatits T; Paternostro R; Salzl P; Reiberger T; Peck-Radosavljevic M; Quehenberger P; Hofer H; Trauner M; Ferenci P; Ferlitsch A
    Dig Liver Dis; 2016 Oct; 48(10):1194-9. PubMed ID: 27476467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
    Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rodenticidal hepatotoxicity: Raised plasma Von Willebrand factor levels predict in-hospital survival and preliminary report of the outcome of Von Willebrand factor reducing management protocol.
    Sardar D; Mathews N; Mammen J; Nair SC; Jacob S; Patel L; Thomas A; Jhanwar S; Sharma A; Sen M; Vijayalekshmi B; Balasubramanian KA; Subramani K; Thomas L; Abhilash KPP; Zachariah U; Elias E; Goel A; Eapen CE
    Indian J Gastroenterol; 2019 Dec; 38(6):527-533. PubMed ID: 32077040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.
    Mandorfer M; Schwabl P; Paternostro R; Pomej K; Bauer D; Thaler J; Ay C; Quehenberger P; Fritzer-Szekeres M; Peck-Radosavljevic M; Trauner M; Reiberger T; Ferlitsch A;
    Aliment Pharmacol Ther; 2018 Apr; 47(7):980-988. PubMed ID: 29377193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease.
    Pomej K; Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Bauer D; Pereyra D; Starlinger P; Stättermayer AF; Pinter M; Trauner M; Quehenberger P; Reiberger T; Mandorfer M
    Dig Liver Dis; 2022 Oct; 54(10):1376-1384. PubMed ID: 35871985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.